Non categorizzato Bristol Myers to buy RayzeBio for $4.1 billion Dicembre 26, 2023 0 commenti Bristol Myers Squibb announced on Tuesday in a statement that it has struck a definitive merger deal with RayzeBio, Inc. worth $4.1 billion or $62.50 per share in cash. The boards of directors of both… About the author:
Get involved!
Comments